Antimicrobials currently available

A survey of current available chemical data, suggests that methylated flavones and, to a lesser extent flavonols, frequently aglycones, are the main classes of antimicrobial and antiviral flavonoids found in medicinal plants. Some of these compounds have been isolated by bioassay-guided fractionation, after previously detecting activity on the part of the plant. 

Several model plants, including 0. sativa, A. thaliana, Z. mays, G. max, and Medicago truncatula, for which genome information is currently available,219 are a rich source of antimicrobial metabolites. Genetic and reverse genetic approaches are providing evidence for the biological importance of antimicrobial compounds in host defense mechanisms. 

Members of this group have the widest spectrum of all currently available antimicrobials, being... 

There is a recognised need for antimicrobial additives in plastics and all types of surface coatings to maintain then-integrity and appearance. The current available laboratory test methods do not always provide a good indication of performance and some could be open to misinterpretation. In addition, the use of additives for claims of antibacterial... 

Crinitol, (1), is a diterpene diol whose properties can in some ways be taken as representative of the current challenges in studying and finding uses for secondary plant metabolites. It is readily availability from a natural source and has a relatively uncomplicated structure despite this, its function in the plant is not fully clarified. As will be discussed below, crinitol shows a modest level of antimicrobial and other biological activity. We can already control many troublesome microorganisms that contaminate food and cosmetics with natural products, including plant secondary metabolites, that are currently available. Nevertheless, discovery... 

The range of kits currently available for the Charm II system and their applications are given in Table 5.5. The test manufacturer claims that the Charm II tests are capable of detecting compounds belonging to the antimicrobial class at or below their defined MRLs (or USFDA tolerances, as indicated) within the relevant matrix, including, milk, urine, serum, animal tissue, honey, and other substances at concentrations of interest to regulatory agencies. 

Up to the present, the perfect antibiotic has not been found. [67] The problem is, that our armamentarium of drugs is facing a multitude of diverse pathogens, which have perfected their survival strategies under permanent selection pressure over millions of years. Microorganisms are able to adapt to changing conditions of their environment by rapid mutations. For each new antibiotic, it is only a matter of time, before resistance ruins its antimicrobial efficacy. There is a continuous race between the innovation cycle for new drugs and the reoccurrence of bacterial resistance. While the time it takes to develop a new pharmaceutical compound cannot be shortened at will, every effort should be made to ensure an extended therapeutic benefit of currently available antibiotics. 

A recent review has discussed the many and varied chanical species that may be used as antimicrobial agents, of which silver has been much researched of late. This is because not only is it a non-toxic, broad spectrum antimicrobial, but it may be applied as a nanoparticulate form and so is easily introduced into fibres themselves instead of topically applied as finishes. However, there are concerns regarding its contribution towards microbial resistance. Of special interest to this review is the means of application and the fabric and garment issues which optimize the overall protective effectiveness. As already stated for silver, many agents may be introduced into the polymer melt or solution prior to extrusion into filaments (or films) and a number of these have been listed. A few currently available examples are ... 

The ability to promote proliferation of COS-1 fibroblast cells over this conductive scaffold was evaluated and these nanofibrous blends are suggested as tissue engineering scaffolds and showed promise as functional wound dressings that may eliminate deficiencies of currently available antimicrobial dressings. 

Two biocides are currently available DOW Antimicrobial 7287 and DOW Antimicrobial 8536. They are 20% and 5% active formulations (respectively) of 2,2-dibromo-3-nitri1opropionamide (DBNPA). These industrial antimicrobials are registered by the Environmental Protection Agency (EPA) for specific end-uses. 

---